An article in the LA Times suggested that patients should not necessarily trust newly approved drugs because the data in the clinical trials might tell the whole story. While the move by GSK to open the books on clinical trials is a good one transparency has to be an accepted way of doing business for biopharma.
POST SUMMARY: According to Makovsky Health and Kelton Research just 8% of U.S. Internet users, ages 66 and older, cited pharmaceutical company websites—the lowest response rate across all age groups. Instead, seniors were more likely to turn to WebMD, cited by 48%. Of the 80% of Americans willing to visit a Pharma-sponsored website, those 66 and older were more likely to visit the site if a healthcare professional recommended it (52%).
POST SUMMARY: According to the Financial Times “Nima Ahmadi, co-founder of Bioniq Health, a digital health start-up based in Palo Alto, California, says: “The noise-to-signal ratio in this space (mobile health) is one of the highest I have seen. There’s a lot of people doing a lot of things without a lot of traction.” Indeed doctor’s are concerned about the new world of health apps and mobile health
POST SUMMARY: A new Harris Poll finds Americans favor generic prescription drugs over brand name products by a considerable margin. Eighty-one percent of those who buy prescription drugs say they would purchase generics more often than brand name drugs. A 42% subset goes so far as to assert that they would “always” choose to buy a generic drug. Older generations are especially likely to indicate that they would always go with generics (50% Matures, 44% Baby Boomers, and 46% Gen X vs. 33% Millennials).
POST SUMMARY: DTC marketing’s objective, in the past, was to drive new Rx’s. Marketers ran commercials and patients went into their doctor to request the product or get a sample, but today the environment in which we market is more complex and filled with a lot of noise. So how do DTC marketers cut through to ensure their marketing is still relevant?
A survey finds that a majority of Americans have tried to find information about health care prices before getting care, including 21 percent who have compared prices across multiple providers. Most of those who have compared prices say they saved money. We also found that the majority of Americans do not believe higher-priced care is necessarily of better quality. And most say insurance companies should be required to make public how much they pay doctors for medical services.
In 2014, the United States made significant progress in cancer care as demonstrated by improvement in the five- year cancer survival rate for many cancer types and a record 14.5 million cancer survivors, as well as by the availability of 10 new drugs and several new tests for the diagnosis, treatment, or management of cancer according to a report from ASCO.